Skip to main content
. 2016 Mar 9;6:23. doi: 10.1186/s13550-016-0173-z

Fig. 2.

Fig. 2

Illustrative example of BSI analysis and PSA change after treatment with enzalutamide at 12-week treatment follow-up. Lesions detected and classified as metastatic by the neural network of the automated EXINI platform for BSI calculation are highlighted in red